Home
Market Capitalization of Jfl Life Sciences Ltd

JFL Life Sciences Ltd
NSE: JFLLIFE
Market Cap
Key Highlights
- The Market Cap of JFL Life Sciences Ltd is ₹ 65 crore as of 28 Apr 25 .
- The Latest Trading Price of JFL Life Sciences Ltd is ₹ 19.7 as of 28 Apr 15:30 .
- The Dividend Payouts of JFL Life Sciences Ltd is ₹ 0.25 as of Sep 13, 2024 .

JFL Life Sciences Ltd
NSE: JFLLIFE
Share Price
Market Price of JFL Life Sciences Ltd
1M
1Y
3Y
5Y
Last Ten Days Market Price
Date | |
---|---|
28 Apr 2025 | 19.7 |
25 Apr 2025 | 20.45 |
23 Apr 2025 | 20.3 |
22 Apr 2025 | 20.35 |
21 Apr 2025 | 20.55 |
17 Apr 2025 | 21.6 |
16 Apr 2025 | 21.7 |
15 Apr 2025 | 20.9 |
11 Apr 2025 | 20.05 |
09 Apr 2025 | 19.1 |
SWOT Analysis Of JFL Life Sciences Ltd
BlinkX Score for JFL Life Sciences Ltd
Asset Value vs Market Value of JFL Life Sciences Ltd
Market Value
₹ 0
Asset Value
₹ 0
* All values are in ₹ crores
Competitive Comparison of Market Cap
Key Valuation Metric of JFL Life Sciences Ltd
Historical P/E Ratio of JFL Life Sciences Ltd
The price-to-earnings ratio (P/E ratio) is a valuation measure calculated by dividing a company's current share price by its earnings per share. P/E Ratio Formula P/E ratio = (CMP of share/ Earning per share) Types of Price to Earning Ratio 1. Forward P/E ratio: It is calculated by simply dividing the price of a single unit of a company along with the estimated earnings of a company derived from its future earning guidance. 2. Trailing P/E ratio: It is the most common metric used by investors where past earnings of a company over a period are considered.
Historical P/E Ratio of JFL Life Sciences Ltd
Historical Revenue of JFL Life Sciences Ltd
Revenue term means the amount of money a company earns from its primary business activities such as the sales of its products & services.\r\r\n\r\r\nTypes of Revenue:\r\r\n\r\r\n1. Operating revenue: It refers to the income generated from the core business activities, which are sales of goods or services rendered.\r\r\n\r\r\n2. Non-Operating revenue: It is the income generated from secondary sources unrelated to the primary business. Examples include rents, dividends, interest, and royalty fees.\r\r\n\r\r\nFormula for Revenue:\r\r\n\r\r\nThe formula for calculating revenue is based on two goods & services:\r\r\n\r\r\nFor goods:\r\r\nRevenue = Avg unit price x Number of Units sold\r\r\n\r\r\nFor services:\r\r\nRevenue = Avg unit price x Number of Customers served.
Historical Revenue of JFL Life Sciences Ltd
Historical EBITDA of JFL Life Sciences Ltd
PBIDT stands for Profit Before Interest, Depreciation, and Taxes. It is a financial metric that measures a company's profitability before accounting for interest expenses, depreciation of assets, and taxes. Formula to calculate PBIDT: PBIDT = Net Income + Interest + Depreciation + Taxes or PBIDT = Operating Income + Depreciation + Taxes PBIDT vs EBITDA vs EBIT vs EBT: Here is a brief explanation of the differences: - PBIDT (Profit Before Interest, Depreciation, and Taxes) includes taxes in its calculation, unlike EBITDA. - EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) excludes taxes and interest, focusing on operational performance. - EBIT (Earnings Before Interest and Taxes) excludes interest and taxes, providing a measure of core operational profitability. - EBT (Earnings Before Taxes) includes all operating income but does not account for interest expenses. Conclusion: PBIDT, similar to EBITDA, is a measure of operational profitability but includes taxes in its calculation.
Historical EBITDA of JFL Life Sciences Ltd
Historical Net Profit of JFL Life Sciences Ltd
Net profit is the amount of money a company retains after accounting for all expenses, depreciation, interest, taxes, and other deductions.\r\r\n\r\r\nNet Profit formula is expressed as:\r\r\n\r\r\nNet Profit = Total Revenue - Total Expense\r\r\n\r\r\nNet Profit Margin Ratio:\r\r\n\r\r\nNet Profit Margin Ratio = Net Profit / Total Revenue
Historical Net Profit of JFL Life Sciences Ltd

JFL Life Sciences Ltd
NSE: JFLLIFE
DIVIDENDPAYOUT
About JFL Life Sciences Ltd
- JFL Life Sciences Limited was incorporated as JFL Life Sciences Private Limited' on April 25, 2010 as a Private Limited Company.
- Pursuant to a Special Resolution held on February 10, 2022, Company converted from a Private Limited to Public Limited Company and name of the Company was changed to JFL Life Sciences Limited', on March 3, 2022.
- The Company manufactures and market pharmaceutical products.
- Its product portfolio consists of Dry powder injections, Tablets & Capsules (B-Lactam) solid oral dosage form, Tablet and Capsules (general) and Oral Rehydration Solutions (ORS). Head quartered in Ahmedabad, Gujarat, Company is engaged in the business of manufacturing of pharmaceutical products.
- With market presence in PAN India, products of JFL is supplied to 10 developed and developing countries throughout the World.
JFL Life Sciences Ltd News Hub
Board of JFL Life Sciences recommends final dividend
JFL Life Sciences announced that the Board of Directors of the Company at its meeting held on 2 Augu
Read more
02 Aug 24
JFL Life Sciences to hold board meeting
JFL Life Sciences will hold a meeting of the Board of Directors of the Company on 31 August 2024. Po
Read more
24 Aug 24
JFL Life Sciences AGM scheduled
JFL Life Sciences announced that the 14th Annual General Meeting (AGM) of the company will be held o
Read more
02 Sept 24
JFL Life Sciences announces board meeting date
JFL Life Sciences will hold a meeting of the Board of Directors of the Company on 27 March 2025. Pow
Read more
20 Mar 25